Bifeprofen, a cytochrome P450 2C9 ( CYP2C9 ) inhibitor, exhibits dose-dependent inhibition (75 μM, 50%).
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Others | Products > Signaling Pathways > Cytochrome P450
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.